IP Library › Granted Patent US 7,517,853
Granted Patent B2
US 7,517,853 · App. 10/553,014 · Granted Apr 14, 2009

Somatostatin-dopamine chimeric analogs

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,517,853
App. No.
10/553,014
Granted
Apr 14, 2009
Kind
B2
Abstract

The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions.

Claims (2)

1. A chimeric analog: Dop2-DLys(Dop2)-cyclo[Cys-Tyr-DTrp-Lys-Abu-Cys]-Thr-NH 2 , or a pharmaceutically acceptable salt thereof.

2. A method of eliciting a dopamine receptor agonist effect in a subject in need thereof, comprising administering an effective amount of the chimeric analog of claim 1 to a subject in need thereof.

Assignments (3)
CHANGE OF NAME Recorded Jul 23, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D`APPLICATIONS SCIENTIFIQUES
To: IPSEN PHARMA S.A.S.
Reel/Frame 022994/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2005
From: DONG, ZHENG XIN; CULLER, MICHAEL DEWITT; SHEN, YEELANA
To: BIOMEASURE, INCORPORATED
Reel/Frame 017311/0637 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2005
From: BIOMEASURE, INCORPORATED
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 017317/0211 →